#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CS

Clinical Oncology - Issue 2/2026

Editorial

79

Není ct jako CT

Review

86

Treatment of Castleman disease from the perspective of the year 2026

Z. Adam, Z. Řehák, I. Boichuk, T. Horváth, Z. Adamová, M. Štork, L. Pour

99

Ewing sarcoma – current diagnostic and therapeutic approaches

A. Nohejlová Medková, P. Pacas, K. Kopečková

105

Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer – a review of current evidence and perspectives

A. Pirshtuk, T. Büchler, V. Vymetálková

Case Report

112

Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene – a rare finding simulating malignancy

V. Bartoš, B. Hudec, E. Baloghová

117

Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case

Y. Maezawa, T. Terada, H. Kobayashi, G. Ohara, T. Saito, N. Takayashiki, H. Satoh

Oncology in Images

122

FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?

Z. Řehák, M. Palácová, S. Soboličová, P. Fabian

Letter to Editor

126

Cancer patients admitted to intensive care unit

M. Uchiyama, Y. Maezawa, H. Satoh, R. Hasegawa

127

Nádory GIT – chemoterapie a precizní léčba se synergicky doplňují

134

Snižování škod rizikového chování v onkologické prevenci

NUVR Reports

140

AKTUALITY Z NÁRODNÍHO ÚSTAVU PRO VÝZKUM RAKOVINY

Clinical Oncology

Issue 2

2026 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#